Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma
about
EZH2 in normal hematopoiesis and hematological malignanciesMYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical managementBiology of double-hit B-cell lymphomasBCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphomaTargeting MYC Expression through G-Quadruplexes.The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomasMyc roles in hematopoiesis and leukemiaRefining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas.C-MYC aberrations as prognostic factors in diffuse large B-cell lymphoma: a meta-analysis of epidemiological studiesMolecular classification, pathway addiction, and therapeutic targeting in diffuse large B cell lymphomaGenetic lesions in diffuse large B-cell lymphomasMYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphomaMYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression shows evidence of active B-cell receptor signaling by quantitative immunofluorescence.Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma.Molecular cytogenetics of lymphoma: where do we stand in 2010?MYC oncogene in myeloid neoplasias.The impact of MYC rearrangements and "double hit" abnormalities in diffuse large B-cell lymphoma.MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice.Double hit lymphoma: from biology to therapeutic implications.Dual expression of MYC and BCL2 proteins predicts worse outcomes in diffuse large B-cell lymphoma.Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.The clinicopathologic spectrum of mature aggressive B cell lymphomas.A unique subtype of diffuse large B-cell lymphoma primarily involving the bone marrow, spleen, and liver, defined by fluorodeoxyglucose-positron emission tomography combined with computed tomography.Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases.Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas.Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma.Angelica gigas Nakai and Decursin Downregulate Myc Expression to Promote Cell Death in B-cell Lymphoma.Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP
P2860
Q26779821-8EEE0BD7-8B1A-4C5D-B518-00568887EBFCQ26785379-67642E9A-B681-4ED8-8D22-9E93B4DDA47DQ26825581-C05C6376-F8EB-4434-96E6-FBCDB0D2D4F6Q34339662-2EA3BAC8-17D6-42A6-9A5B-F038B6D44FCCQ34352558-ED8F5294-5221-4516-AC9B-976FCA8B6181Q34371078-C4CDFBF1-2115-4787-835F-C68178439473Q34972364-F230B528-BDA4-4DDB-BB68-4A88769B79A6Q35006744-EFE2A81D-3AFC-484F-9E40-B5C19E218032Q35150618-B5C97D3D-8A08-4428-A10F-A730B076F330Q35797583-4846FE96-C3C5-4F98-8504-1E337FFFCEADQ35974341-A0CA2DEE-E7B3-4354-A29B-1CB16C51B1DAQ36210875-869C84BE-C6F0-40FA-8536-70B55138316DQ37212700-E13263BC-335B-4E37-88B4-15C2ECDCE18CQ37650198-1A063FFC-5FE3-4682-9C71-978457E881D0Q37677852-4B90ABBA-EDBD-4D8C-A718-F4FBAC47BD25Q37831961-63DA46B7-B577-4296-9E7E-4C643F2EF086Q38036610-BE23ACA6-2E52-44D0-9A73-E75482E4DA23Q38124735-BD2996A4-D8E0-4E7D-8BAD-DF01000C1287Q38233772-3E577076-0468-4369-90F8-44EB783CF25DQ38719071-0ECDF168-CFA0-4E7E-A528-63E8EB3F4484Q38831667-F4BC0EF3-7649-4EA9-B5AC-66637B938796Q38958331-F3F8CB98-4D46-4AB0-BE28-45F0BF088B53Q41896892-0CF41282-29AD-45F2-8BE1-F2DFFD92E612Q48170832-2CBA164F-D5E3-4B27-BBB3-590BD1B25CA2Q48847317-1B3CEEB6-7842-4EB8-A42A-BD2814539B8EQ48956040-29326830-2500-4369-8976-BA2C8C42985BQ51514379-7B0EB0B6-5C42-4175-AE1F-86A590B85E41Q52760136-189452BA-B1B8-449F-9210-AF0A51981271Q55713061-B7068BEC-0990-45DC-989C-619E039BD16FQ58011085-C01C74A6-C6EC-4DAA-8448-2340192E28A9
P2860
Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Increased MYC gene copy number ...... diffuse large B-cell lymphoma
@ast
Increased MYC gene copy number ...... diffuse large B-cell lymphoma
@en
type
label
Increased MYC gene copy number ...... diffuse large B-cell lymphoma
@ast
Increased MYC gene copy number ...... diffuse large B-cell lymphoma
@en
prefLabel
Increased MYC gene copy number ...... diffuse large B-cell lymphoma
@ast
Increased MYC gene copy number ...... diffuse large B-cell lymphoma
@en
P2093
P2860
P1433
P1476
Increased MYC gene copy number ...... diffuse large B-cell lymphoma
@en
P2093
Charles H Mosher
Christopher J Stasik
Daniel O Persky
Hiroaki Nitta
James R Cook
Joseph M Unger
Lisa M Rimsza
Raymond R Tubbs
Sarah T Wilkinson
Thomas M Grogan
P2860
P304
P356
10.3324/HAEMATOL.2009.012864
P577
2010-04-01T00:00:00Z